Correlation Between Effector Therapeutics and Grifols SA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Effector Therapeutics and Grifols SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Effector Therapeutics and Grifols SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Effector Therapeutics and Grifols SA ADR, you can compare the effects of market volatilities on Effector Therapeutics and Grifols SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Effector Therapeutics with a short position of Grifols SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Effector Therapeutics and Grifols SA.

Diversification Opportunities for Effector Therapeutics and Grifols SA

-0.72
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Effector and Grifols is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Effector Therapeutics and Grifols SA ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Grifols SA ADR and Effector Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Effector Therapeutics are associated (or correlated) with Grifols SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Grifols SA ADR has no effect on the direction of Effector Therapeutics i.e., Effector Therapeutics and Grifols SA go up and down completely randomly.

Pair Corralation between Effector Therapeutics and Grifols SA

Given the investment horizon of 90 days Effector Therapeutics is expected to generate 24.58 times more return on investment than Grifols SA. However, Effector Therapeutics is 24.58 times more volatile than Grifols SA ADR. It trades about 0.13 of its potential returns per unit of risk. Grifols SA ADR is currently generating about -0.08 per unit of risk. If you would invest  0.02  in Effector Therapeutics on September 2, 2025 and sell it today you would earn a total of  0.00  from holding Effector Therapeutics or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy98.48%
ValuesDaily Returns

Effector Therapeutics  vs.  Grifols SA ADR

 Performance 
       Timeline  
Effector Therapeutics 

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Effector Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Effector Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.
Grifols SA ADR 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Grifols SA ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's technical and fundamental indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Effector Therapeutics and Grifols SA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Effector Therapeutics and Grifols SA

The main advantage of trading using opposite Effector Therapeutics and Grifols SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Effector Therapeutics position performs unexpectedly, Grifols SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Grifols SA will offset losses from the drop in Grifols SA's long position.
The idea behind Effector Therapeutics and Grifols SA ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Money Managers
Screen money managers from public funds and ETFs managed around the world